Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
4 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to bioAffinity Technologies, Inc.’s names, not what it holds today.
Patents granted
4
4 utility, 1976 to Dec 31, 2025
Granted in 2025
1
in the last year the record reads
Applications published
8
3 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
bioAffinity Technologies, Inc. its own name
US, as the owner printed on each patent
5 publishedbioAffinity Technologies, Inc. its own name
named as the applicant on its applications, in US
3 publishedNames not counted (1)
Therapeutics, LLC
Only generic words.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| May 20, 2025 | 12,305,171 | Compositions and methods for treating cancer | Biotechnology | bioAffinity Technologies, Inc. |
| Aug 16, 2016 | 9,417,241 | 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine (TCPP) and kit for use with detecting cancer | Analysis of biological materials | bioAffinity Technologies, Inc. |
| Mar 10, 2015 | 8,975,038 | Method for determining presence of carcinomic cells with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine | Analysis of biological materials | bioAffinity Technologies, Inc. |
| Nov 4, 2014 | 8,877,509 | System and method for analyzing samples labeled with 5, 10, 15, 20 tetrakis (4-carboxyphenyl) porphine (TCPP) | Analysis of biological materials | bioAffinity Technologies, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Nov 20, 2025 | 2025/0354156 | Compositions and Methods for Treating Cancer | Biotechnology | bioAffinity Technologies, Inc. |
| Jun 12, 2025 | 2025/0191706 | DETECTION OF EARLY-STAGE LUNG CANCER IN SPUTUM USING AUTOMATED FLOW CYTOMETRY AND MACHINE LEARNING | Analysis of biological materials | bioAffinity Technologies, Inc. |
| Feb 27, 2025 | 2025/0069747 | DETECTION OF EARLY-STAGE LUNG CANCER IN SPUTUM USING AUTOMATED FLOW CYTOMETRY AND MACHINE LEARNING | Measurement | bioAffinity Technologies, Inc. |
| Sep 12, 2024 | 2024/0302360 | COMPOSITIONS AND METHODS FOR USE IN FLOW CYTOMETRY | Analysis of biological materials | bioAffinity Technologies, Inc. |
| Feb 2, 2023 | 2023/0035774 | Compositions and Methods for Treating Cancer | Biotechnology | bioAffinity Technologies, Inc. · patent 12,305,171 granted from it |
| Apr 8, 2021 | 2021/0102957 | SYSTEM AND METHOD FOR DETERMINING LUNG HEALTH | Analysis of biological materials | bioAffinity Technologies, Inc. |
| Jun 25, 2015 | 2015/0177245 | Method for Prognosing Response to Cancer Therapy with 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine | Analysis of biological materials | bioAffinity Technologies, Inc. · patent 9,417,241 granted from it |
| Jun 11, 2015 | 2015/0160197 | System and Method for Analyzing Samples Labeled with 5, 10, 15, 20 Tetrakis (4-Carboxyphenyl) Porphine (TCPP) | Analysis of biological materials | bioAffinity Technologies, Inc. |
What it applied for, 2024 to 2025: Analysis of biological materials 2 · Measurement 1 · Biotechnology 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.